ImmunoMolecular Therapeutics’ Scientific Co-founder Presents a Novel Small Molecule Approach to Blocking the Autoimmunity in Type 1 Diabetes - Press Release
Digital Journal,
BROOMFIELD, Colo.--(Business Wire)--ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small…